Number of patients receiving each therapy regimen
Target marrow dose from 166Ho-DOTMP . | No melphalan . | Melphalan, 140 mg/m2 . | Melphalan, 140 mg/m2 + TBI . | Melphalan, 200 mg/m2 . |
---|---|---|---|---|
20Gy | 0 | 5 | 6 | 4 |
30Gy | 0 | 4 | 9 | 7 |
40Gy | 1 | 7 | 10 | 30 |
Target marrow dose from 166Ho-DOTMP . | No melphalan . | Melphalan, 140 mg/m2 . | Melphalan, 140 mg/m2 + TBI . | Melphalan, 200 mg/m2 . |
---|---|---|---|---|
20Gy | 0 | 5 | 6 | 4 |
30Gy | 0 | 4 | 9 | 7 |
40Gy | 1 | 7 | 10 | 30 |